HOWL
HOWL clinical trials: Werewolf Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Werewolf Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
HOWL on the catalyst calendar · HOWL registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026Actual | NCT05479812Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected...Werewolf Therapeutics, Inc. · Metastatic Solid Tumor | HOWLLeadMRKCollaborator | Phase 1 | Completed | Locked | Locked | Locked |
| Apr 23, 2026Actual | NCT06939283A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors...Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors | HOWLLead | Phase 1/Phase 2 | Completed | Locked | Locked | Locked |
| Dec 23, 2024Actual | NCT05678998WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin LymphomaWerewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors | HOWLLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Apr 22, 2026ActualPhase 1NCT05479812Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected...Werewolf Therapeutics, Inc. · Metastatic Solid TumorCompletedHOWLLeadMRKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2026ActualPhase 1/Phase 2NCT06939283A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors...Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid TumorsCompletedHOWLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2024ActualPhase 1NCT05678998WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin LymphomaWerewolf Therapeutics, Inc. · Advanced or Metastatic Solid TumorsCompletedHOWLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner